The U.S. Food and Drug Administration approved the weight loss drug Belviq for people who are overweight or obese and have one or more weight-related health problems, the agency announced today.
"Obesity threatens the overall well-being of patients and is a major public health concern," Dr. Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research, said in a statement. "The approval of this drug, used responsibly in combination with a healthy diet and lifestyle, provides a...
Full Story